γ-Secretase: once and future drug target for Alzheimer’s disease
Michael S. Wolfe
Abstract
1. Alzheimer’s disease (AD) is a devastating neurodegenerative disorder affecting over 6 million people in the U.S.A. and over 40 million people worldwide [1]. The gradual loss of neurons, particul...
Topics & Concepts
DrugDiseaseDrug discoveryDrug targetAlzheimer's diseaseDrug developmentMedicineNeurosciencePharmacologyBiologyBioinformaticsInternal medicineAlzheimer's disease research and treatmentsNuclear Receptors and SignalingComputational Drug Discovery Methods